Incretin Mimetics For Type 2 Diabetes

Content provided by Healthwise
small text medium text large text

Examples


Brand Name Generic Name
Byettaexenatide

Exenatide is the first of a new type of medication called incretin mimetics. The U.S. Food and Drug Administration (FDA) approved exenatide to treat people with type 2 diabetes who have not been able to control their blood sugar levels with oral medicines. It is given as a shot 2 times a day, before morning and evening meals.

Previous Chapter | Next Chapter


Healthwise Logo
Last updated: June 16, 2008
Author: Caroline Rea, RN, BS, MS
Reviewed By: Caroline S. Rhoads, MD - Internal Medicine, Matthew I. Kim, MD - Endocrinology & Metabolism
Editors: Susan Van Houten, RN, BSN, MBA, Pat Truman, MATC

This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, and AOL Body Advertising Policy. Read more about our content partners.

ADVERTISEMENT

Drugs & Supplements News

Diseases & Conditions

patient-doctor Getty Images

Get information about ailments that affect your life.

Family Health

man-doctor Getty Images

Get advice to keep your family healthy on Aol Health.

© Copyright 2010 AOL Inc. All Rights Reserved